Drug Discovery · Redwood City, CA · Founded 2019 · In IPO Registration
Developer of therapeutic medicines designed to provide curative treatments for serious viral and liver diseases. Bluejay Therapeutics is based in Redwood City, CA and was founded in 2019. Its last known valuation is $820 million. It has raised $243 million across 3 recorded rounds; the latest was an $182 million Series C in May 2024.
Last price · $/share
—
Implied valuation
$820.0M
Total raised
$243.0M
Last round
Later Stage VC (Series C)
May 2024
Team — not yet on record
No current team members for Bluejay Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bluejay Therapeutics with a free account
·The complete investor list: 13 names
·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
